New York City, NY -- (SBWIRE) -- 01/06/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY), Federal National Mortgage Assctn Fnni Me (OTCBB:FNMA), Softbank Corp. (Japan) (OTCMKTS:SFTBY), Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT)
Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) gained 1.37%, trading on 229,654 shares, to end the trade at $69.61. If we look at its trading history of the past 52 weeks, the share price suffered a low of $50.99 and was moved to the maximum level of $70.58. The stock changed hands in a range of $69.10 to $68.68, bringing its market capitalization to about $240.17 billion. Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It belongs to the Roche Group that operates through subsidiaries and associated companies around the world. It discovers, develops and provides diagnostic and therapeutic products and services from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring.
Will RHHBY Continue To Move Higher? Find Out Here
Federal National Mortgage Assctn Fnni Me (OTCBB:FNMA) declined -1.01%, to complete the trading session at $2.95, with a total volume of 4.94 million shares. The stock, on average, trades on a volume of 18.44 million shares. In the past 52 weeks, the share price has not declined below $0.26 and above $5.44. It floated in a range of $2.92 to $2.99 during the last trading session, with a beta value of 3.43. Its market capitalization now moved to about $3.42 billion. Federal National Mortgage Association Fannie Mae is a government-sponsored enterprise (GSE) chartered by the United States Congress to support liquidity and stability in the secondary mortgage market, where mortgage-related assets are purchased and sold.
Is it the Right to Grab FNMA after the Recent Slump? Get Free Trend Analysis Here
Softbank Corp. (Japan) (OTCMKTS:SFTBY) recorded a gain of 0.36% and was in a range of $42.92-$43.71 before closing at $43.26. The share price hit its 52-week low of $16.53 and $44.25 was the best price. The stock completed the day with a total volume of 286,543 shares, versus an average volume of 348,369 shares.
Why Should Investors Buy SFTBY After The Recent Gain? Just Go Here and Find Out
Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT) declined -4.78%, bringing its market capitalization around $362.53 million. The total number of shares that changed hands during the session was 4.28 million shares, as compared to average trading volume of 1.56 million shares. The share price, after opening at $2.98, made a high of $3.00 and hovered above $2.51 to end the day at $2.59. Provectus Pharmaceuticals, Inc. is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications. The Company develops and focuses to license or market and sells its two prescription drug candidates, PV-10 and PH-10.
Will PVCT Reach the Bottom after Yesterday’s Correction? Find Out Here
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)